The impact of donor age and recipient age on clinical course and immune response after organ transplantation

Transplantation Reviews

Volumn 20, Issue 4, 2006, Pages 179-188

  Denecke, Christian ^a,b   Habicht, Antje ^b   Chandraker, Anil ^a,b   Tullius, Stefan G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; GERIATRIC PATIENT; GRAFT RECIPIENT; HOSPITAL ADMISSION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; ORGAN DONOR; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; REVIEW;

EID: 33751091728     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2006.07.005     Document Type: Review

References (98)

1. Sung R.S., Guidinger M.K., Lake C.D., McBride M.A., Greenstein S.M., Delmonico F.L., et al. Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation 79 9 (2005) 1257-1261
2. Ojo A.O., Hanson J.A., Meier-Kriesche H., Okechukwu C.N., Wolfe R.A., Leichtman A.B., et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 12 3 (2001) 589-597
3. Siddiqi N., McBride M.A., and Hariharan S. Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Kidney Int 65 5 (2004) 1906-1913
4. Basar H., Soran A., Shapiro R., Vivas C., Scantlebury V.P., Jordan M.L., et al. Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation 67 8 (1999) 1191-1193
5. Tullius S.G., Reutzel-Selke A., Egermann F., Nieminen-Kelha M., Jonas S., Bechstein W.O., et al. Contribution of prolonged ischemia and donor age to chronic renal allograft dysfunction. J Am Soc Nephrol 11 7 (2000) 1317-1324
6. Cohen B., Smits J.M., Haase B., Persijn G., Vanrenterghem Y., and Frei U. Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 20 1 (2005) 34-41
7. Pascher A., Pratschke J., Neuhaus P., and Tullius S.G. Modifications of immune regulations with increasing donor & recipient age. Ann Transplant 9 1 (2004) 72-73
8. OPTN/SRTR annual report 2005. http://www.optn.org/data/annual.Report.asp.
9. Merion R.M., Ashby V.B., Wolfe R.A., Distant D.A., Hulbert-Shearon T.E., Metzger R.A., et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 294 21 (2005) 2726-2733
10. Gill J.S., Tonelli M., Johnson N., Kiberd B., Landsberg D., and Pereira B.J. The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int 68 5 (2005) 2345-2351
11. Oniscu G.C., Brown H., and Forsythe J.L. How old is old for transplantation?. Am J Transplant 4 12 (2004) 2067-2074
12. Otero-Ravina F., Rodriguez-Martinez M., Gude F., Gonzalez-Juanatey J.R., Valdes F., and Sanchez-Guisande D. Renal transplantation in the elderly: does patient age determine the results?. Age Ageing 34 6 (2005) 583-587
13. Palomar R., Ruiz J.C., Zubimendi J.A., Cotorruelo J.G., de Francisco A.L., Rodrigo E., et al. Acute rejection in the elderly recipient: influence of age in the outcome of kidney transplantation. Int Urol Nephrol 33 1 (2002) 145-148
14. Meier-Kriesche H.U., Srinivas T.R., and Kaplan B. Interaction between acute rejection and recipient age on long-term renal allograft survival. Transplant Proc 33 7-8 (2001) 3425-3426
15. Fabrizii V., Kovarik J., Bodingbauer M., Kramar R., Horl W.H., and Winkelmayer W.C. Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation 80 5 (2005) 582-589
16. Neipp M., Jackobs S., Jaeger M., Schwarz A., Lueck R., Gwinner W., et al. Living kidney donors >60 years of age: is it acceptable for the donor and the recipient?. Transpl Int 19 3 (2006) 213-217
17. Johnson S.R., Khwaja K., Pavlakis M., Monaco A.P., and Hanto D.W. Older living donors provide excellent quality kidneys: a single center experience (older living donors). Clin Transplant 19' 5 (2005) 600-606
18. Weiss-Salz I., Mandel M., Galai N., Nave I., Boner G., Mor E., et al. Factors associated with primary and secondary graft failure following cadaveric kidney transplant. Clin Transplant 18 5 (2004) 571-575
19. Stratta R.J., Rohr M.S., Sundberg A.K., Armstrong G., Hairston G., Hartmann E., et al. Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. Ann Surg 239 5 (2004) 688-695
20. Stratta R.J., Rohr M.S., Sundberg A.K., Farney A.C., Hartmann E.L., Moore P.S., et al. Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality?. Ann Surg 243 5 (2006) 594-603
21. Meier-Kriesche H.U., Ojo A., Hanson J., Cibrik D., Lake K., Agodoa L.Y., et al. Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation 69 5 (2000) 885-889
22. Meier-Kriesche H.U., Friedman G., Jacobs M., Mulgaonkar S., Vaghela M., and Kaplan B. Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols. Transplantation 68 10 (1999) 1496-1502
23. Johnson D.W., Nicol D.L., Purdie D.M., Preston J.M., Brown A.M., Hawley C.M., et al. Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?. Transplantation 73 7 (2002) 1158-1163
24. Meier-Kriesche H.U., Morris J.A., Chu A.H., Steffen B.J., Gotz V.P., Gordon R.D., et al. Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients. Nephrol Dial Transplant 19 11 (2004) 2864-2869
25. Arbogast H., Huckelheim H., Schneeberger H., Illner W.D., Tarabichi A., Fertmann J., et al. A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trial. Clin Transplant 19 3 (2005) 309-315
26. Cacho D.T., Cusi L.I., Pique A.A., Villar P.B., Reyes L.I., Alvarez-Vijande R., et al. Elderly donor kidney transplant: factors involved in graft survival. Transplant Proc 37 9 (2005) 3690-3692
27. Segoloni G.P., Messina M., Squiccimarro G., Mazzucco G., Torta E., Leonardi G., et al. Preferential allocation of marginal kidney allografts to elderly recipients combined with modified immunosuppression gives good results. Transplantation 80 7 (2005) 953-958
28. Spanish Monotherapy Study Group. Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: a multicenter randomized study. Spanish Monotherapy Study Group. Transplant Proc 26 5 (1994) 2522-2524
29. Benedetti E., Matas A.J., Hakim N., Fasola C., Gillingham K., McHugh L., et al. Renal transplantation for patients 60 years or older. A single-institution experience. Ann Surg 220 4 (1994) 445-458
30. Vincenti F., Kirkman R., Light S., Bumgardner G., Pescovitz M., Halloran P., et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 338 3 (1998) 161-165
31. Brenner B.M., Cohen R.A., and Milford E.L. In renal transplantation, one size may not fit all. J Am Soc Nephrol 3 2 (1992) 162-169
32. Halloran P.F., Melk A., and Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 10 1 (1999) 167-181
33. Melk A., Schmidt B.M., Vongwiwatana A., Rayner D.C., and Halloran P.F. Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am J Transplant 5 6 (2005) 1375-1382
34. Melk A., Schmidt B.M., Takeuchi O., Sawitzki B., Rayner D.C., and Halloran P.F. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int 65 2 (2004) 510-520
35. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908 (2000) 244-254
36. Gjertson D.W. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS update. Clin Transpl (1996) 343-360
37. Terasaki P.I., Gjertson D.W., Cecka J.M., Takemoto S., and Cho Y.W. Significance of the donor age effect on kidney transplants. Clin Transplant 11 5 Pt 1 (1997) 366-372
38. Meier-Kriesche H.U., Cibrik D.M., Ojo A.O., Hanson J.A., Magee J.C., Rudich S.M., et al. Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc 50 1 (2002) 14-17
39. De Fijter J.W., Mallat M.J., Doxiadis I.I., Ringers J., Rosendaal F.R., Claas F.H., et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 12 7 (2001) 1538-1546
40. Shoskes D.A., Parfrey N.A., and Halloran P.F. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 49 1 (1990) 201-207
41. Khoruts A., Mondino A., Pape K.A., Reiner S.L., and Jenkins M.K. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J Exp Med 187 2 (1998) 225-236
42. Zinkernagel R.M., and Hengartner H. Antiviral immunity. Immunol Today 18 6 (1997) 258-260
43. Penfield J.G., Dawidson I.A., Ar'Rajab A., Kielar M.A., Jeyarajah D.R., and Lu C.Y. Syngeneic renal transplantation increases the number of renal dendritic cells in the rat. Transpl Immunol 7 4 (1999) 197-200
44. Sidman C.L., Luther E.A., Marshall J.D., Nguyen K.A., Roopenian D.C., and Worthen S.M. Increased expression of major histocompatibility complex antigens on lymphocytes from aged mice. Proc Natl Acad Sci U S A 84 21 (1987) 7624-7628
45. Goes N.., Sims T., Urmson J., Vincent D., Ramassar V., and Halloran P.F. Disturbed MHC regulation in the IFN-gamma knockout mouse. Evidence for three states of MHC expression with distinct roles for IFN-gamma. J Immunol 155 (1995) 4559-4566
46. Lung T.L., Saurwein-Teissl M., Parson W., Schönitzer D., and Grubeck-Loebenstein B. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 18 16 (2000) 1606-1612
47. Ordemann R., Hutchinson R., Friedman J., Burakoff S.J., Reddy P., Duffner U., et al. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 109 9 (2002) 1249-1256
48. Castle S.C., Uyemura K., Crawford W., Wong W., and Makinodan T. Antigen presenting cell function is enhanced in healthy elderly. Mech Ageing Dev 107 2 (1999) 137-145
49. Halloran P.F., Homik J., Goes N., Lui S.L., Urmson J., Ramassar V., et al. The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 29 1-2 (1997) 79-81
50. Reutzel-Selke A., Filatenkov A., Jurisch A., Denecke C., Martins P.N.A., Pascher A., et al. Grafts from elderly donors elicit a stronger immune response in the early period posttransplantation: a study in a rat model. Transplant Proc 37 (2005) 382-383
51. Wick G., Jansen-Durr P., Berger P., Blasko I., and Grubeck-Loebenstein B. Diseases of aging. Vaccine 18 16 (2000) 1567-1583
52. Solana R., and Mariani E. NK and NK/T cells in human senescence. Vaccine 18 16 (2000) 1613-1620
53. Hsu H.C., Scott D.K., and Mountz J.D. Impaired apoptosis and immune senescence-cause or effect?. Immunol Rev 205 (2005) 130-146
54. Ivory K., Martin R., and Hughes D.A. Significant presence of terminally differentiated T cells and altered NF-kappaB and I-kappaBalpha interactions in healthy ageing. Exp Gerontol 39 4 (2004) 567-576
55. Suh Y. Cell signaling in aging and apoptosis. Mech Ageing Dev 123 8 (2002) 881-890
56. Aggarwal S., and Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. Immunol 160 4 (1998) 1627-1637
57. Bryl E., and Witkowski J.M. Decreased proliferative capability of CD4(+) cells of elderly people is associated with faster loss of activation-related antigens and accumulation of regulatory T cells. Exp Gerontol 39 4 (2004) 587-595
58. Pawelec G., Akbar A., Caruso C., Solana R., Grubeck-Loebenstein B., and Wikby A. Human immunosenescence: is it infectious?. Immunol Rev 205 (2005) 257-268
59. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8 4 (2002) 379-385
60. Fulop T., Larbi A., Wikby A., Mocchegiani E., Hirokawa K., and Pawelec G. Dysregulation of T-cell function in the elderly: scientific basis and clinical implications. Drugs Aging 22 7 (2005) 589-603
61. Linton P.J., Haynes L., Klinman N.R., and Swain S.L. Antigen-independent changes in naive CD4 T cells with aging. J Exp Med 184 5 (1996) 1891-1900
62. Haynes L., Eaton S.M., Burns E.M., Randall T.D., and Swain S.L. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A 100 25 (2003) 15053-15058
63. Fagnoni F.F., Vescovini R., Passeri G., Bologna G., Pedrazzoni M., Lavagetto G., et al. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 95 9 (2000) 2860-2868
64. Li S.P., Cai Z., Shi W., Brunmark A., Jackson M., and Linton P.J. Early antigen-specific response by naive CD8 T cells is not altered with aging. J Immunol 168 12 (2002) 6120-6127
65. Utsuyama M., Wakikawa A., Tamura T., Nariuchi H., and Hirokawa K. Impairment of signal transduction in T cells from old mice. Mech Ageing Dev 93 1-3 (1997) 131-144
66. Linton P.J., Li S.P., Zhang Y., Bautista B., Huynh Q., and Trinh T. Intrinsic versus environmental influences on T-cell responses in aging. Immunol Rev 205 (2005) 207-219
67. + T cells as determined by four-color flow cytometry analysis. J Gerontol A Biol Sci Med Sci 54 3 (1999) B116-B123
68. Messaoudi I., Lemaoult J., Guevara-Patino J.A., Metzner B.M., and Nikolich-Zugich J. Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense. J Exp Med 200 10 (2004) 1347-1358
69. Olsson J., Wikby A., Johansson B., Lofgren S., Nilsson B.O., and Ferguson F.G. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish Longitudinal OCTO Immune Study. Mech Ageing Dev 121 1-3 (2000) 187-201
70. + T cells: reversal by interleukin-12 stimulation. Blood 101 9 (2003) 3543-3549
71. +CD25 high regulatory T cells increases with age. Clin Exp Immunol 140 3 (2005) 540-546
72. + T-cells in type 1 diabetes. Diabetes 54 5 (2005) 1407-1414
73. - T cells in aged mice are hyporesponsive and exhibit suppressive activity. J Immunol 170 4 (2003) 1675-1682
74. Meier-Kriesche H.U., Ojo A.O., Cibrik D.M., Hanson J.A., Leichtman A.B., Magee J.C., et al. Relationship of recipient age and development of chronic allograft failure. Transplantation 70 2 (2000) 306-310
75. Jassal S.V., Opelz G., and Cole E. Transplantation in the elderly: a review. Geriatr Nephrol Urol 7 3 (1997) 157-165
76. Lufft V., Kliem V., Tusch G., Dannenberg B., and Brunkhorst R. Renal transplantation in older adults: is graft survival affected by age? A case control study. Transplantation 69 5 (2000) 790-794
77. Fritsche L., Horstrup J., Budde K., Reinke P., Giessing M., Tullius S., et al. Old-for-old kidney allocation allows successful expansion of the donor and recipient pool. Am J Transplant 3 11 (2003) 1434-1439
78. Tullius S.G., Reutzel-Selke A., Bachmann U., Jurisch A., Nieminen-Kelha M., Pratschke J., et al. Influence of recipient and donor age on long-term renal allograft function in an experimental model. Transplant Proc 33 7-8 (2001) 3345-3346
79. Pascher A., Reutzel-Selke A., Jurisch A., Bachmann U., Heidenhain C., Nickel P., et al. Alterations of the immune response with increasing recipient age are associated with reduced long-term organ graft function of rat kidney allografts. Transplantation 76 11 (2003) 1560-1568
80. Lou H., Kodama T., Zhao Y.J., Maurice P., Wang Y.N., Katz N., et al. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression. Circulation 94 12 (1996) 3355-3361
81. Heeger P.S., Greenspan N.S., Kuhlenschmidt S., Dejelo C., Hricik D.E., Schulak J.A., et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 163 4 (1999) 2267-2275
82. DeKruyff R.H., Rinnooy E., Kan A., Weksler M.E., and Siskind G.W. Effect of aging on T-cell tolerance induction. Cell Immunol 56 1 (1980) 58-67
83. Wells A.D., Li X.C., Li Y., Walsh M.C., Zheng X.X., Wu Z., et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 5 11 (1999) 1303-1307
84. + regulatory T cells. Transplantation 79 2 (2005) 147-156
85. Zheng X.X., Sanchez-Fueyo A., Sho M., Domenig C., Sayegh M.H., and Strom T.B. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19 4 (2003) 503-514
86. + T cells. Immunol Rev 205 (2005) 220-228
87. Burrows S.R., Khanna R., Burrows J.M., and Moss D.J. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med 179 4 (1994) 1155-1161
88. Blattman J.N., Antia R., Sourdive D.J., Wang X., Kaech S.M., Murali-Krishna K., et al. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med 195 5 (2002) 657-664
89. Welsh R.M., Markees T.G., Woda B.A., Daniels K.A., Brehm M.A., Mordes J.P., et al. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol 74 (2000) 2210-2218
90. Lakkis F.G., and Sayegh M.H. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol 14 9 (2003) 2402-2410
91. Nasr I.W., Wang Y., Gao G., Deng S., Diggs L., Rothstein D.M., et al. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells. J Immunol 174 10 (2005) 6161-6168
92. Valujskikh A., Pantenburg B., and Heeger P.S. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2 6 (2002) 501-509
93. Adams A.B., Williams M.A., Jones T.R., Shirasugi N., Durham M.M., Kaech S.M., et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111 12 (2003) 1887-1895
94. Yamada K., Gianello P.R., Ierino F.L., Fishbein J., Lorf T., Shimizu A., et al. Role of the thymus in transplantation tolerance in miniature swine: II. Effect of steroids and age on the induction of tolerance to class I mismatched renal allografts. Transplantation 67 3 (1999) 458-467
95. Vagefi P.A., Ierino F.L., Gianello P.R., Shimizu A., Kamano C., Sachs D.H., et al. Role of the thymus in transplantation tolerance in miniature swine: IV. The thymus is required during the induction phase, but not the maintenance phase, of renal allograft tolerance. Transplantation 77 7 (2004) 979-985
96. Kamano C., Vagefi P.A., Kumagai N., Yamamoto S., Barth R.N., LaMattina J.C., et al. Vascularized thymic lobe transplantation in miniature swine: thymopoiesis and tolerance induction across fully MHC-mismatched barriers. Proc Natl Acad Sci U S A 101 11 (2004) 3827-3832
97. Tullius SG, Lehmann M, Filatenkov A, Schmidt H, Reutzel-Selke A, Schröder G, et al. The allograft by itself induces regulatory T cells-immunosuppression needs to spare this mechanism to induce tolerance [submitted for publication].
98. Pascher A., Prösch S., Filatenkow A., Reutzel-Selke A., Lehmann M., Pratschke J., et al. Rat-cytomegalovirus infection interferes with anti-CD4-mAb (RIB 5/2)-induced tolerance and induces chronic allograft dysfunction. Am J Transplant 5 Suppl 11 (2005) 365